|
|
Volumn 20, Issue 12, 2012, Pages 3807-3815
|
|
Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors
a
a
a
a
a
a,b
|
|
Author keywords
Amino acid ureido derivatives; Aminopeptidase N; Anti cancer; Inhibitors; Synthesis
|
|
Indexed keywords
(1 HYDROXYCARBAMOYL 3 METHYL BUTYL) CARBAMIC ACID BENZYL ESTER;
(1 HYDROXYCARBAMOYL 3 METHYL BUTYL) CARBAMIC ACID PHENETHYL ESTER;
2 (3 BENZYL UREIDO) N HYDROXY 2 (1 METHYL) PROPYL ACETAMAIDE;
2 (3 BENZYL UREIDO) N HYDROXY 2 (2 METHYLSULFANYL) ETHYL ACETAMAIDE;
2 (3 BENZYL UREIDO) N HYDROXY 2 BENZYL ACETAMAIDE;
2 (3 BENZYL UREIDO) N HYDROXY 2 ISOPROPYL ACETAMIDE;
2 (3 BENZYL UREIDO) N HYDROXY ACETAMAIDE;
2 (3 BENZYL UREIDO) N HYDROXY PROPIONAMIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY 2 (1 METHYL) PROPYL ACETAMIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY 2 (2 METHYL) PROPYL ACETAMAIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY 2 (2 METHYLSULFANYL) ETHYL ACETAMIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY 2 BENZYL ACETAMIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY 2 ISOPROPYL ACETAMIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY ACETAMAIDE;
2 (3 PHENETHYL UREIDO) N HYDROXY PROPIONAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY 2 (1 METHYL) PROPYL ACETAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY 2 (2 METHYL) PROPYL ACETAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY 2 BENZYL ACETAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY 2 ISOPROPYL ACETAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY ACETAMIDE;
2 (3 TERT BUTYL UREIDO) N HYDROXY PROPIONAMIDE;
2 (TERT BUTYL UREIDO) N HYDROXY 2 (2 METHYLSULFANYL) ETHYL ACETAMIDE;
2 [3 (1 HYDROXYCARBAMOYL 3 METHYL BUTYL) URIEDO] 4 METHYL PENTANOIC ACID HYDROXYAMIDE;
AMINO ACID DERIVATIVE;
AMINO ACID UREIDO DERIVATIVE;
BESTATIN;
MICROSOMAL AMINOPEPTIDASE;
N HYDROXY 2 [3 (1 HYDROXYCARBAMOYL 3 PHENYL ETHYL) URIEDO] 3 PHENYL PROPIONAMIDE;
PROTEIN INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTINEOPLASTIC ACTIVITY;
CANCER CELL;
CANCER INHIBITION;
CANCER INVASION;
CONCENTRATION RESPONSE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG EFFICACY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HUMAN;
HUMAN CELL;
IC 50;
AMINO ACIDS;
ANTIGENS, CD13;
ANTINEOPLASTIC AGENTS;
CELL MOVEMENT;
CELL PROLIFERATION;
DRUG DESIGN;
DRUG SCREENING ASSAYS, ANTITUMOR;
HUMANS;
PROTEASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
TUMOR CELLS, CULTURED;
|
|
EID: 84861580001
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2012.04.035 Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (15)
|
